|
|
Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
|
1R43CA225169-01
|
$295,205
|
$295,205
|
SNOOK, KEVIN
|
ACTUATED MEDICAL, INC.
|
|
|
Oral formulation for novel inhibitor of Ras driven cancers
|
1R43CA217502-01A1
|
$300,000
|
$99,000
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
1R44CA224460-01
|
$299,805
|
$299,805
|
Daunch, William
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-02
|
$520,564
|
$260,282
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$72,923
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
OPTION PERIOD 2- PATIENT ACCRUAL AND TREATMENT 12/30/2016-12/29/2017
|
261201500022C
|
$453,713
|
$453,713
|
UNKNOWN, UNKNOWN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-05
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
|
1R33CA225248-01
|
$1,744,991
|
$1,744,991
|
KELLY, RYAN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
|
1R01CA211176-01
|
$362,569
|
$362,569
|
ELSEA, SARAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$5,917
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$5,944
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$6,113
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$12,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$162,656
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-03
|
$473,915
|
$473,915
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
|
1U01CA214254-01
|
$1,075,356
|
$1,075,356
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$733
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$1,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$24,467
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-10
|
$382,500
|
$126,225
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
|
1R21CA212827-01
|
$267,258
|
$267,258
|
WONG, WESLEY
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
$590,572
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
$219,537
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
$63,974
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$104,424
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$557,256
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
5U24CA210986-02
|
$1,288,045
|
$437,935
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
5U01CA199253-03
|
$807,776
|
$266,566
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
$1,912
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
|
1R03CA219725-01
|
$80,000
|
$40,000
|
PETROSIUTE, AGNE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Role of CRABP-II in pancreatic cancer metastasis
|
1R03CA201738-01A1
|
$80,000
|
$80,000
|
YU, SHUILIANG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
2R44CA183265-02A1
|
$1,008,442
|
$1,008,442
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
|
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
|
1R01CA211098-01A1
|
$431,066
|
$431,066
|
FLICK, MATTHEW
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
|
4R44CA210770-02
|
$1,464,585
|
$1,464,585
|
PEREZ, KRISTY
|
CIVATECH ONCOLOGY, INC.
|
|
|
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
|
5R44CA174025-03
|
$1,094,011
|
$1,094,011
|
SUREBAN, SRIPATHI
|
COARE BIOTECHNOLOGY, INC.
|
|
|
Finding Novel Pancreatic Cancer Oncogenes Using an Innovative 3D Culture System
|
5F32CA192904-03
|
$47,190
|
$47,190
|
BAKER, LINDSEY
|
COLD SPRING HARBOR LABORATORY
|
|
|
Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer
|
5K99CA204725-02
|
$128,235
|
$128,235
|
ENGLE, DANNIELLE
|
COLD SPRING HARBOR LABORATORY
|
|
|
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
|
5F32CA180717-03
|
$63,078
|
$63,078
|
HWANG, CHANG-IL
|
COLD SPRING HARBOR LABORATORY
|
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
$100,690
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
|
Preclinical Models for Cancer Therapeutic Development
|
5R50CA211506-02
|
$174,117
|
$174,117
|
PARK, YOUNGKYU
|
COLD SPRING HARBOR LABORATORY
|
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
3P01CA013106-45S1
|
$2,165,000
|
$108,250
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
|
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
|
1R01CA188134-01A1
|
$510,684
|
$510,684
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
|
CSHL Cancer Center Support Grant
|
5P30CA045508-30
|
$4,395,404
|
$1,010,943
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
5R01CA190092-04
|
$552,684
|
$552,684
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
|
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
|
5R44CA200186-03
|
$1,002,483
|
$1,002,483
|
HUMBLET, VALERIE
|
COLLAGEN MEDICAL, LLC
|
|
|
Roles and Regulation of wild-type and mutant forms of p53
|
2P01CA087497-16A1
|
$1,945,587
|
$214,015
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$6,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$3,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Total relevant funding to Pancreas for this search: $178,331,745
|
